C9789 HCPCS code: Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed
C9789 is the HCPCS Level II code for instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed. In 2024 Medicare paid an average of $847.50 per service for C9789 across 164 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 1 per day on outpatient hospital claims. In 2024, about 20 clinicians billed Medicare for C9789 for 37 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | C codes — Outpatient PPS (hospital outpatient temporary codes) |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 53 |
| BETOS category | P5E |
| Added | 2023-10-01 |
| Last action effective | 2023-10-01 |
Who bills C9789 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 20 |
| Medicare beneficiaries | 37 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for C9789, 2024–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2024 | 164 | 37 | $1,065.75 | $847.50 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1 | Code Descriptor / CPT Instruction |
| practitioner claims | 1 | Code Descriptor / CPT Instruction |
What changed for C9789
- 2023-10-01: C9789 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code C9789?
C9789 is the HCPCS Level II code for instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed. Short descriptor: "Instill pharm renal pelvis".
How much does Medicare pay for C9789?
In 2024, the average Medicare payment was $847.50 per service (average allowed $1,065.75).
Does Medicare cover C9789?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of C9789 can be billed per day?
1 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).
Related C97 codes
- C9724 — Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy
- C9725 — Placement of endorectal intracavitary applicator for high intensity brachytherapy
- C9726 — Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure
- C9727 — Insertion of implants into the soft palate; minimum of three implants
- C9728 — Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple
- C9733 — Non-ophthalmic fluorescent vascular angiography
- C9734 — Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance
- C9735 — Anoscopy; with directed submucosal injection(s), any substance
- C9737 — Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)
- C9738 — Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)
- C9739 — Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants
- C9740 — Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under C9789
- Watch C9789 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for C9789
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.